Poster (Scientific congresses and symposiums)
Impact of Immunogenicity on Clinical Outcomes in Postmenopausal Women with Osteoporosis: Results from a Randomized Controlled Phase 3 Study to Compare CT-P41 (Proposed Denosumab Biosimilar) and Reference Denosumab
Reginster, Jean-Yves; Silverman, Stuart L.; Czerwinski, Edward et al.
2024ACR Convergence 2024
Editorial reviewed
 

Files


Full Text
Poster - Impact of Immunogenicity on Clinical Outcomes in Postmenopausal Women with Osteoporosis. ACR2024.pdf
Author postprint (354.64 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Public health, health care sciences & services
Author, co-author :
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique
Silverman, Stuart L.
Czerwinski, Edward
Borowy, Przemyslaw
Budlewski, Tomasz
Kwiatek, Joanna
Postol, Svitlana
Põder, Airi
Supronik, Jerzy
Kim, SungHyun
Suh, JeeHye
Yang, GoEun
Han, NooRi
Kim, NaHyun
Bae, SeoHee
More authors (5 more) Less
Language :
English
Title :
Impact of Immunogenicity on Clinical Outcomes in Postmenopausal Women with Osteoporosis: Results from a Randomized Controlled Phase 3 Study to Compare CT-P41 (Proposed Denosumab Biosimilar) and Reference Denosumab
Publication date :
2024
Event name :
ACR Convergence 2024
Event place :
Washington DC, United States
Event date :
14-19 Novembre 2024
Audience :
International
Peer reviewed :
Editorial reviewed
Available on ORBi :
since 26 November 2024

Statistics


Number of views
17 (4 by ULiège)
Number of downloads
20 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi